Contralateral recurrence of aggressive fibromatosis in a young woman: A case report and review of the literature

Schmoyer,Christopher  J.; Brereton,Harmar  D.; Blomain,Eric  W.

doi:10.3892/ol.2015.3215

Contralateral recurrence of aggressive fibromatosis in a young woman: A case report and review of the literature

Authors:
- Christopher J. Schmoyer
- Harmar D. Brereton
- Eric W. Blomain
View Affiliations

Affiliations: Clinical Faculty, Department of Medicine, The Commonwealth Medical College, Scranton, PA 18509, USA
Published online on: May 18, 2015 https://doi.org/10.3892/ol.2015.3215
Pages: 325-328

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Aggressive fibromatosis (AF) is a benign non-encapsulated tumor of mesenchymal origin, with a tendency for local spread along fascial planes. Local invasion can lead to extensive morbidity and even mortality due to destruction of the bones, organs and soft tissues. This rare lesion is observed 1,000 times more frequently in patients with familial adenomatous polyposis or Gardner's syndrome due to the inheritance of the adenomatous polyposis coli (APC) gene. While AF does not metastasize, local recurrence is common. Distant recurrence is extremely rare, but is observed in those with a germ line APC mutation. The present study details the case of a 20‑year‑old woman with a melanoma of the right shoulder, treated definitively with surgery. The patient then developed a painful mass at the surgical site; a surgical biopsy demonstrated that the mass was AF. The patient was treated with surgical resection, radiation therapy, and a course of tamoxifen. Five years later, the patient presented with left forearm pain and diminished range of motion due to an infiltrating mass. This was excised and a clinical diagnosis of recurrent AF was made, in this patient lacking familial predisposition to the disease.

View Figures

View References

1	Stout AP: Juvenile fibromatoses. Cancer. 7:953–978. 1954. View Article : Google Scholar : PubMed/NCBI
2	Hosalkar HS, Torbert JT, Fox EJ, Delaney TF, Aboulafia AJ and Lackman RD: Musculoskeletal desmoid tumors. J Am Acad Orthop Surg. 16:188–198. 2008.PubMed/NCBI
3	Gurbuz AK, Giardiello FM, Petersen GM, et al: Desmoid tumours in familial adenomatous polyposis. Gut. 35:377–381. 1994. View Article : Google Scholar : PubMed/NCBI
4	Hartley JE, Church JM, Gupta S, McGannon E and Fazio VW: Significance of incidental desmoids identified during surgery for familial adenomatous polyposis. Dis Colon Rectum. 47:334–338. 2004. View Article : Google Scholar : PubMed/NCBI
5	Hallet M: NINDS myotatic reflex scale. Neurology. 43:27231993. View Article : Google Scholar
6	Tejpar S, Nollet F, Li C, et al: Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene. 18:6615–6620. 1999. View Article : Google Scholar : PubMed/NCBI
7	Alman BA, Li C, Pajerski ME, Diaz-Cano S and Wolfe HJ: Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am J Pathol. 151:329–334. 1997.PubMed/NCBI
8	Aberle H, Bauer A, Stappert J, Kispert A and Kemler R: β-Catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16:3797–3804. 1997. View Article : Google Scholar : PubMed/NCBI
9	Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S and Polakis P: Binding of GSK3β to the APC-β-catenin complex and regulation of complex assembly. Science. 272:1023–1026. 1996. View Article : Google Scholar : PubMed/NCBI
10	Ghanbari-Azarnier R, Sato S, Wei Q, Al-Jazrawe M and Alman BA: Targeting stem cell behavior in desmoid tumors (aggressive fibromatosis) by inhibiting hedgehog signaling. Neoplasia. 15:712–719. 2013. View Article : Google Scholar : PubMed/NCBI
11	Wu C, Nik-Amini S, Nadesan P, Stanford WL and Alman BA: Aggressive fibromatosis (desmoid tumor) is derived from mesenchymal progenitor cells. Cancer Res. 70:7690–7698. 2010. View Article : Google Scholar : PubMed/NCBI
12	Escobar C, Munker R, Thomas JO, Li BD and Burton GV: Update on desmoid tumors. Ann Oncol. 23:562–569. 2012. View Article : Google Scholar : PubMed/NCBI
13	Rhim JH, Kim JH, Moon KC, et al: Desmoid type fibromatosis in the head and neck: CT and MR imaging characteristics. Neuroradiology. 55:351–359. 2013. View Article : Google Scholar : PubMed/NCBI
14	Nishio J, Aoki M, Nabeshima K, Iwasaki H and Naito M: Imaging features of desmoid-type fibromatosis in the teres major muscle. In Vivo. 27:555–559. 2013.PubMed/NCBI
15	Owens CL, Sharma R and Ali SZ: Deep fibromatosis (desmoid tumor): Cytopathologic characteristics, clinicoradiologic features and immunohistochemical findings on fine-needle aspiration. Cancer. 111:166–172. 2007. View Article : Google Scholar : PubMed/NCBI
16	Qi H, Cal Cin P, Hernandez JM, et al: Trisomies 8 and 20 in desmoid tumors. Cancer Genet Cytogenet. 92:147–149. 1996. View Article : Google Scholar : PubMed/NCBI
17	Fiore M, Rimareix F, Mariani L, et al: Desmoid-type fibromatosis: A front-line conservative approach to select patients for surgical treatment. Ann Surg Oncol. 16:1587–1593. 2009. View Article : Google Scholar : PubMed/NCBI
18	Bonvalot S, Eldweny H, Haddad V, et al: Extra-abdominal primary fibromatosis: Aggressive management could be avoided in a subgroup of patients. Eur J Surg Oncol. 34:462–468. 2008. View Article : Google Scholar : PubMed/NCBI
19	van Broekhoven DL, Verhoef C, Elias SG, et al: Local recurrence after surgery for primary extra-abdominal desmoid type fibromatosis. Br J Surg. 100:1214–1219. 2013. View Article : Google Scholar : PubMed/NCBI
20	Ballo MT, Zagars GK, Pollack A, Pisters PW and Pollack RA: Desmoid Tumor: Prognosis factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol. 17:158–167. 1999.PubMed/NCBI
21	Gluck I, Griffith KA, Biermann JS, Feng FY, Lucas DR and Ben-Josef E: Role of radiotherapy in the management of desmoid tumors. Int J Radiat Oncol Biol Phys. 80:787–792. 2011. View Article : Google Scholar : PubMed/NCBI
22	Shin SH, Ko KR, Cho SK, Choi YL and Seo SW: Surgical outcome of desmoid tumors: adjuvant radiotherapy delayed the recurrence, but did not affect long-term outcomes. J Surg Oncol. 108:28–33. 2013. View Article : Google Scholar : PubMed/NCBI
23	Klein WA, Miller HH, Anderson M and DeCosse JJ: The use of indomethacin, sulindac and tamoxifen for the treatment of desmoid tumors associated with familial polyposis. Cancer. 60:2863–2868. 1987. View Article : Google Scholar : PubMed/NCBI
24	Janinis J, Patriki M, Vini L, Aravantinos G and Whelan JS: The pharmacological treatment of aggressive fibromatosis: A systematic review. Ann Oncol. 14:181–190. 2003. View Article : Google Scholar : PubMed/NCBI
25	Devata S and Chugh R: Desmoid tumors: A comprehensive review of the evolving biology, unpredictable behavior and myriad of management options. Hematol Oncol Clin North Am. 27:989–1005. 2013. View Article : Google Scholar : PubMed/NCBI
26	Sundaram M, Duffrin H, McGuire MH and Vas W: Synchronous multicentric desmoid tumors (aggressive fibromatosis) of the extremities. Skeletal Radiol. 17:16–19. 1988. View Article : Google Scholar : PubMed/NCBI
27	Antal I, Szendroi M, Kovacs G, Nagykalnai T and Entz L: Multicentric extraabdominal desmoid tumor: a case report. J Cancer Res Clin Oncol. 120:190–193. 1994. View Article : Google Scholar
28	Watanabe K, Ogura G, Tajino T and Suzuki T: Extra-abdominal desmoid fibromatosis: Two familial cases with synchronous and metachronous multicentric hyalinizing nodules. Histopathology. 41:118–121. 2002. View Article : Google Scholar : PubMed/NCBI
29	Eccles DM, van der Lujit R, Breukel C, et al: Hereditary desmoid disease due to a frameshift mutation at codon 1924 of the APC gene. Am J Hum Genet. 59:1193–201. 1996.PubMed/NCBI